Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorCentre Hospitalier St Anne

About this trial

This non-interventional study aims to validate the French version of a meningioma-specific quality-of-life questionnaire (MQOL-FR) and to describe health-related quality of life in adults diagnosed with an intracranial meningioma.

Participants will be invited to complete online questionnaires through a secure REDCap link. After reading the study information and recording their non-opposition, participants will complete: (1) MQOL-FR (meningioma-specific), (2) EQ-5D-5L (generic health-related quality of life), and (3) FACT-Br (brain tumor-specific quality of life). The questionnaire session takes approximately 30-45 minutes and can be completed in more than one sitting using a REDCap access code. There is no additional visit and no change in usual care.

The study will recruit adults (≥18 years) with a meningioma diagnosis based on imaging and/or confirmed by surgery, through the GHU Paris-Sainte-Anne neurosurgery clinic and through patient/community networks. The goal is to obtain 100 fully completed MQOL-FR questionnaires suitable for psychometric analyses.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of intracranial meningioma on imaging and/or confirmed by surgery

Disqualifiers

Pregnant or breastfeeding

Individuals deprived of liberty by judicial/administrative decision or under compulsory psychiatric care

Insufficient French language proficiency/comprehension

Unable to complete the questionnaires independently

Trial design

Treatments tested in this trial

  • Quality-of-life questionnaire administration

Treatment groups

238 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators